Novo Nordisk A/S ADR (NVO)

$127.76 1.97 (1.57%)

13:35 EDT NVO Stock Quote Delayed 30 Minutes

What Would George Soros Do? 7 Stocks the Billionaire’s Fund Bought & Sold in Q4

By Muslim Farooque, InvestorPlace Contributor Feb 28, 2024

Dive into the insightful analysis on George Soros stocks in Q4 highlighting the foresight of an investing titan

Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now

3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024

Wealth Generators: 3 Growth Stocks You’ll Regret Not Buying in 2024

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.99M

Day's Range $125.99 - $127.82

52-Week Range $75.56 - $138.28

Dividend & Yield $1.77 (1.38%)

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

From InvestorPlace
From the Web

Meet the Next Trillion-Dollar Companies: Our Top 7 Picks

By Jeremy Flint, InvestorPlace Contributor Feb 15, 2024

These future trillion-dollar stocks are on their way to mythic valuation, supported by strong underlying fundamentals and prospects.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

By Paul R. La Monica, InvestorPlace Contributor Feb 6, 2024

Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

By Rich Duprey, InvestorPlace Contributor Feb 5, 2024

The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

By William White, InvestorPlace Writer Feb 5, 2024

Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares.

The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone

By Rich Duprey, InvestorPlace Contributor Feb 1, 2024

Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.

3 Phenomenal Stock-Split Stocks You Should Be Buying Now

By Rich Duprey, InvestorPlace Contributor Jan 22, 2024

Because the market sees stock splits as a sign of future growth these stock-split stocks could be tomorrow's winners.

Global Giants: 3 Multinational Corporations to Outperform in 2024

By Charles Munyi, InvestorPlace Contributor Jan 4, 2024

Participate in the growth of the global economy and consumption through these leading global stocks for 2024.

Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?

By William White, InvestorPlace Writer Jan 4, 2024

Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 4, 2024

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!

7 Low-Volatility Stocks for Stable Growth in 2024

By Muslim Farooque, InvestorPlace Contributor Dec 21, 2023

Wager on these stocks to buy for stable growth, handpicked for their low volatility and potential to weather economic headwinds.

The New Magnificent 7: 7 Stocks Rising to Prominence

By Alex Sirois, InvestorPlace Contributor Dec 15, 2023

The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

By Chandler Capital, InvestorPlace Contributor Dec 13, 2023

These biotech stocks with promising pipelines are showing some major promise and growth potential for the new year.

7 Stocks Set to Capitalize on the Coming Year-End Rally

By Alex Sirois, InvestorPlace Contributor Nov 24, 2023

The stock market is poised to rally at the year end as multiple positive factors conspire to push certain sectors higher.

3 Consumer Goods Stocks That Will Define the Next Decade

By Joel Baglole, InvestorPlace Contributor Nov 21, 2023

These companies can be expected to continue shaping our lives for the foreseeable future thanks to their strong brands.

7 A-Rated Retirement Stocks for Your November Buy List

By Louis Navellier and the InvestorPlace Research Staff Nov 17, 2023

I know very few people who don’t look forward to retirement. Retirement means your life’s labor is done and you’ve achieved your financial goals. Whether…

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

By Alex Sirois, InvestorPlace Contributor Nov 13, 2023

Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

7 Biotech Stocks to Buy for Big-Time Gains

By Louis Navellier and the InvestorPlace Research Staff Nov 10, 2023

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

7 A-Rated Tech Stocks to Buy for November

By Louis Navellier and the InvestorPlace Research Staff Nov 2, 2023

By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.

3 Monster Buy-and-Hold Growth Stocks to Buy Right Now for $1K

By Rich Duprey, InvestorPlace Contributor Oct 27, 2023

These are three growth stocks you will want to buy and never sell if you have $1,000 available to invest today.

Novo Nordisk A/S ADR (NVO)

What Would George Soros Do? 7 Stocks the Billionaire’s Fund Bought & Sold in Q4

Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now

3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024

Wealth Generators: 3 Growth Stocks You’ll Regret Not Buying in 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novo Nordisk A/S ADR (NVO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

Subscriber Sign in